Industry Perspectives: Can Change Orders Be Less Challenging?

Stating the obvious: the clinical trial process is complicated and expensive, and change orders are often viewed as a necessary evil and unavoidable. Change Orders often cause internal friction between operations, outsourcing and finance as well as external friction between the sponsor and the service provider. Join this premier panel that will be discussing the challenges and exploring new, solutions surrounding clinical trial change orders from the biopharma and CRO perspectives. Topics that are covered include: What makes Change Orders so difficult to manage? Discuss perspectives from multiple viewpoints: CRO, biotech, technology toolset. Does the company size matter when managing Change Orders? Do strategic partnership contribute to reducing or streamlining change orders vs. tactical sourcing? How about fixed price agreements? Why do reconciliations take so long? Is the process transparent enough? Can technology aid in better understanding sources and impact of changes? What about related processes such as managing Out-of-Scope trackers and Change Notification Forms (CNFs)? Are these contributing to overall process simplification? Are there tools that can increase visibility into what is being tracked in aggregate? What is your wish list for process improvement?